Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Literature
1.
Newman B (2013) Arm complications after manual whole blood donation and their impact. Transfus Med Rev 27:44–49CrossRefPubMed
Metadata
Title
Arterial Phlebotomy in a Whole Blood Donor and Consequent Adverse Events
Authors
Naveen Agnihotri
Yatendra Mohan Chaturvedi
Ajju Agnihotri
Publication date
01-07-2018
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2018
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0905-x

Other articles of this Issue 3/2018

Indian Journal of Hematology and Blood Transfusion 3/2018 Go to the issue

Images

Non Cutaneous, Non Langerhans Cell Histiocytoses: A Diagnostic Dilemma

Original Article

Prenatal Diagnosis of HbE-β-Thalassemia: Experience of a Center in Western India

Original Article

Engraftment Syndrome: Clinical Features and Predictive Factors in Autologous Stem Cell Transplant

Correspondence

T Cell Prolymphocytic Leukemia (T-PLL): Cutaneous Involvement in an Uncommon Leukemia

Original Article

Vitamin D Deficiency and Its Association with Inflammatory Markers, Lipid Profile and Regulatory T-cells in Pediatric Sickle Cell Disease Patients

Original Article

Acquired Hemophilia A: Experience of a Tertiary Care Institute from North India
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits